Date: February 09, 2023
Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET)
Monoclonal gammopathies (MGs) comprise a broad set of diseases involving the abnormal clonal proliferation of plasma cells. Treatments for MGs range for watchful monitoring to multidrug chemotherapeutic regimens and bone marrow transplant. The clinical laboratory plays a central role in guiding these therapeutic decisions by performing a number of assays that detect monoclonal proteins within the patient's blood or urine. These assays are typically performed as a panel or as part of a reflexive algorithm to improve the accuracy and information yield. However, the complexity of these algorithms requires careful coordination between the medical technologists and the reviewing pathologist. This presentation will cover our institutional experience developing and adopting a computer-based workflow for coordinating and interpreting MG screening panels within the Phoresis (Sebia) computer application.
- Discuss evidence-based practices to screening for monoclonal gammopathies
- Describe a computer-based workflow for integrating pathologist interpretations
- Review the impact of paperless workflows on laboratory productivity
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.